Special issue: Biosimilars 2024

This exclusive special issue from Expert Opinion on Biological Therapy examines the evolving landscape of biosimilars, addressing their clinical, economic, regulatory and market implications, as well as exploring their use in treating specific conditions such as rheumatoid arthritis, osteoporosis and inflammatory bowel disease. Covering topics such as the effectiveness and safety of biosimilar-to-biosimilar transitions, streamlined development processes and market dynamics, this issue highlights the role of biosimilars in improving access to biologic therapies. Read the full issue to access: Editorial: Examining the impact of biosimilar-to-biosimilar transition on effectiveness and safety Report: Short and long-term economic implications of biosimilars Perspective: Streamlining...